How Singapore-Resident NRIs Are Taxed on Indian Investment Income: No Capital Gains Tax at Home, But India Now Wants Its Share

A reader in Singapore emailed me in March, a few weeks before the financial year closed, asking how much Singapore would tax the Rs 40,00,000 long-term gain he had just booked selling Indian shares he had bought in 2020. The honest answer surprised him twice. Singapore would tax that gain at zero, because Singapore has no capital gains tax. India, on the other hand, would tax it at 12.5% under Section 112A, which is the part he had assumed the treaty would wipe out, because a colleague had told him "Singapore residents pay no tax on Indian shares." That advice was correct in 2015 and wrong by 2020. He had the geography of his tax bill exactly backwards: he expected to pay Singapore and escape India, when the truth was the reverse.

The 30-second answer: Singapore has no capital gains tax and runs a largely territorial system, so a Singapore-resident NRI's Indian capital gains and foreign dividends are generally not taxed in Singapore at all. The tax that bites is on the India side. The India-Singapore treaty's old zero-tax-on-shares exemption ended on 1 April 2017: shares acquired before that date stay grandfathered and taxable only in Singapore (zero), but shares acquired on or after 1 April 2017 are taxable in India, short-term at 20% and long-term at 12.5% under the current regime. Indian dividends are taxed in India (TDS, treaty rate 15% with a TRC and Form 10F) and generally not taxed again in Singapore. Net effect: little double taxation, but you now pay Indian tax you did not pay before 2017.

This guide is for the NRI who is tax-resident in Singapore and holds investments in India: shares, mutual funds, property, deposits. It explains why Singapore's tax system is structurally kind to your Indian portfolio, exactly where that kindness comes from (no capital gains tax plus a territorial base, not a treaty gift), and why the one famous treaty advantage, zero Indian tax on share gains, is gone for anything you bought after 2017. It walks through dividends, the worked example my reader needed, and the edge cases that catch careful people: the grandfathering cut-off, what "received in Singapore" means for foreign income, why mutual fund units behave differently from shares, and how derivatives sit. If you want the treaty article numbers and the relief mechanics in full, the companion piece is the India-Singapore DTAA deep dive; this guide is about the investment income itself and the two-country picture around it.

Why Singapore is structurally good for your Indian portfolio

Start with the thing that makes Singapore different from the UK, the US, or Canada for an Indian investor. Singapore has no capital gains tax. Not a low one, not a deferred one, not one with annual exemptions and tapering relief. There is simply no tax on capital gains for individuals, on any asset, Indian or otherwise. When you sell Indian shares, redeem Indian mutual funds, or sell Indian property, Singapore takes nothing from the gain. That is true whether the gain is short-term or long-term, large or small, remitted to Singapore or left in India.

The second structural feature is that Singapore taxes individuals on a territorial basis. Broadly, a Singapore resident is taxed on income sourced in Singapore and on foreign income only in limited cases. For an individual, foreign-sourced income, which includes a dividend from an Indian company, is generally exempt from Singapore tax, even when it is received in Singapore, as long as it is not income from a trade or business carried on through a partnership in Singapore. So your Indian dividend, which is foreign-sourced to a Singapore resident, generally falls outside the Singapore net entirely.

Put the two together and you get the picture that confuses people. When India hands a taxing right to Singapore, the effective tax on that income is frequently zero, not because the treaty grants an exemption but because Singapore declines to tax it under its own domestic rules. India gives up the income, Singapore does not pick it up, and the money falls through the gap legally. This is the same asymmetry that made the old share exemption so valuable, and it is the reason India spent years closing the specific gap that mattered most.

The honest framing is this. Singapore's domestic tax system does most of the work for you. You do not need the treaty to avoid Singapore tax on your Indian gains, because Singapore was never going to tax them in the first place. What you need the treaty for is to reduce the Indian tax, and on capital gains, the treaty no longer does that for new acquisitions. So the modern Singapore NRI's position is not "tax-free Indian investing." It is "Singapore-free, India-taxed," and the planning lives entirely on the Indian side.

The treaty advantage that ended: shares acquired on or after 1 April 2017

For roughly two decades, the headline benefit of being a Singapore-resident NRI was that capital gains on shares of Indian companies were taxable only in Singapore, which taxes no capital gains, so the gain was taxed nowhere. This was not a Singapore peculiarity invented in isolation; it was tied to the Mauritius route. The India-Singapore treaty's capital gains article was deliberately linked to the India-Mauritius treaty, so when India renegotiated Mauritius in 2016 to introduce source-based taxation of share gains, the Singapore treaty followed through the Third Protocol, signed in December 2016 and effective from 1 April 2017.

The Third Protocol switched share gains from residence-based to source-based taxation, with a date test that turns on when you acquired the shares, not when you sell them. The structure has three layers, and getting them straight is the whole game:

• Shares acquired before 1 April 2017 stay grandfathered. Gains on them are taxable only in Singapore, which means zero, however long you hold and whenever you sell. This is the surviving piece of the old advantage.
• Shares acquired on or after 1 April 2017 but before 1 April 2019 sat in a transition window. India could tax the gain, but at no more than 50% of the domestic rate. That window is now historical, and a current sale of such shares is rare, but it exists.
• Shares acquired on or after 1 April 2019 are taxable in India at the full domestic rate, exactly as for any other non-resident, with the treaty giving no relief at all.

So in 2026, for the vast majority of shareholdings, which were bought after 2019, the India-Singapore treaty does nothing for share gains. You pay the Indian rate. The grandfathered category still matters for long-term holders who bought before April 2017 and never sold, and the difference between a grandfathered lot and a post-2019 lot can be a lakh or more on identical shares. But the route that mattered to new money, buy Indian shares as a Singapore resident and pay zero tax anywhere, is shut.

A word on the documentation, because the grandfathering is not automatic. To claim that a gain is taxable only in Singapore, you have to prove the shares were acquired before 1 April 2017 and satisfy the treaty's conditions, which for individuals is straightforward but still requires a Tax Residency Certificate from IRAS and an electronically filed Form 10F. The limitation-of-benefits clause that can deny the exemption is aimed at shell and conduit companies, not individual retail investors, but the burden of evidencing the acquisition date sits with you. Keep the contract notes.

What India actually charges on share gains now

If the treaty gives nothing on a post-2019 holding, the next question is what India charges, because that is now the entire bill. For listed equity shares and equity-oriented mutual funds where Securities Transaction Tax has been paid, the rates after the 23 July 2024 changes are clean:

• Short-term capital gains (held 12 months or less) are taxed at 20% under Section 111A.
• Long-term capital gains (held more than 12 months) are taxed at 12.5% under Section 112A, on the gain above a Rs 1,25,000 annual exemption.

For a non-resident, these gains on listed securities are charged under Section 115AD, which applies the same 20% short-term and 12.5% long-term rates and the same Rs 1,25,000 long-term exemption. The arithmetic and the NRI-specific wrinkles, including how the Rs 1,25,000 exemption interacts with TDS and how the surcharge cap works, are laid out in the capital gains guide for shares and mutual funds. The point for a Singapore resident is that this Indian charge is the final charge. Singapore does not tax the gain, so there is no double tax to relieve, no foreign tax credit to claim, and nothing to report on the Singapore side. India takes its 12.5% or 20% and the matter is closed.

This is the cleanest two-country outcome an NRI can have, and it is worth naming why. In the US, a resident NRI pays the Indian tax and then reports the same gain at home, using a foreign tax credit on Form 67 to avoid paying twice, and frequently faces the PFIC regime on Indian mutual funds on top. In Singapore, none of that machinery exists, because there is no Singapore tax on the gain to create double taxation in the first place. The complexity that defines US-resident and UK-resident Indian investing simply does not arise. The only complexity left is making sure you have correctly paid India, which for a non-resident means TDS at source plus a return, covered below in the edge cases.

Dividends: taxed in India at 15% under the treaty, not taxed again in Singapore

Dividends are where Singapore's territorial system does visible work, so it is worth separating the India side from the Singapore side cleanly.

On the India side, dividends from Indian companies have been taxable income in the shareholder's hands since the 2020 shift away from the dividend distribution tax. A company's registrar deducts TDS under Section 195 at 20% plus surcharge and cess, an effective rate that can reach about 23.3% for an individual non-resident. Article 10 of the India-Singapore treaty caps the rate at 15% for an individual shareholder, and crucially the treaty 15% carries no surcharge or cess, so it is genuinely 15%. To get 15% at source rather than reclaiming the excess later, your IRAS Tax Residency Certificate, your electronically filed Form 10F, and the registrar's beneficial-ownership declaration have to reach each company's registrar before its pre-dividend cut-off. There is no single submission for the whole portfolio; you do it company by company, every year. The mechanics, including which registrars run which cut-offs, are in the NRI dividend tax guide.

On the Singapore side, the dividend is foreign-sourced income to a Singapore resident, and Singapore generally does not tax a foreign dividend received by an individual. So for most Singapore-resident NRIs, the 15% deducted in India is the end of the dividend story. There is nothing more to pay in Singapore, and because Singapore does not tax the dividend, there is no Singapore tax against which to claim a foreign tax credit for the Indian 15%, and nothing to reclaim. The 15% is simply a cost, minimised by claiming the treaty rate at source.

Contrast this with the UAE route. A UAE-resident NRI also enjoys no personal tax at home, but the India-UAE treaty still delivers a treaty capital gains relief on shares that the India-Singapore treaty lost in 2017, which is why the two jurisdictions now diverge sharply on share gains even though both are zero-tax for the resident. If you are weighing residency or comparing the two regimes, the UAE zero-CGT route guide sets out where the UAE treaty still does what Singapore's used to do, and the broader treaty grandfathering story is in the Mauritius and Singapore grandfathering note.

Worked example: a Rs 40,00,000 long-term gain on shares bought in 2020

Take the reader who emailed me. He is tax-resident in Singapore and sells listed Indian shares he bought in 2020, booking a long-term capital gain of Rs 40,00,000. Held more than 12 months, listed, STT paid, so Section 112A applies and the gain is long-term. Walk it through both sides.

Step 1, decide which regime applies. The shares were acquired in 2020, which is on or after 1 April 2019. They fall in the full-rate layer of the Third Protocol. The treaty gives no relief. India taxes the gain at the full domestic rate. There is no grandfathering, no 50% transition cap, nothing.

Step 2, compute the Indian tax under Section 112A.

• Long-term gain: Rs 40,00,000
• Less the annual long-term exemption: Rs 1,25,000
• Taxable long-term gain: Rs 38,75,000
• Tax at 12.5%: Rs 38,75,000 multiplied by 0.125 equals Rs 4,84,375
• Add 4% health and education cess: Rs 4,84,375 multiplied by 0.04 equals Rs 19,375
• Indian tax, including cess: Rs 5,03,750 (surcharge is ignored here; on capital gains under Section 112A the surcharge is capped at 15%, and whether any surcharge applies depends on total income, so treat Rs 5,03,750 as the core LTCG bill before any surcharge)

Step 3, the Singapore side. Singapore has no capital gains tax. The Rs 40,00,000 gain is not taxed in Singapore at all. There is no Singapore charge, no remittance issue on a capital gain, and no foreign tax credit to claim because there is no Singapore tax to relieve. The Indian Rs 5,03,750 is the whole bill across both countries.

Step 4, the pre-2017 counterfactual. Suppose instead he had bought the identical shares in 2015 and held them untouched. They would be grandfathered: the gain would be taxable only in Singapore, which taxes no capital gains, so the Indian tax would be zero and the Singapore tax would be zero. Same Rs 40,00,000 gain, same shares, and the entire Rs 5,03,750 difference turns on nothing but the year of purchase straddling 1 April 2017. That single date is worth just over five lakh on this trade.

The discipline this example teaches is to know your acquisition dates lot by lot. If part of a holding predates April 2017, that part is genuinely tax-free across both countries and you should claim it with a TRC and Form 10F. The part bought after 2019 is fully Indian-taxed and there is no treaty argument that changes it. Mixing the two up, in either direction, is how people either overpay or under-report and walk into interest and penalty.

Edge cases

The general rule (Singapore taxes nothing, India taxes post-2017 gains and dividends) covers most situations, but several edges matter and routinely catch careful investors.

The grandfathering cut-off is an acquisition date, not a holding period. The test is when you bought the shares, not how long you have held them or when you sell. A share bought on 31 March 2017 and sold in 2026 is grandfathered and taxable only in Singapore. A share bought on 1 April 2017 and sold the same day in 2026 is in the transition or full-rate layer depending on the exact date. Bonus shares, rights shares, and shares received in a merger take their own acquisition dates, which can differ from the original lot, so a single "holding" can contain both grandfathered and non-grandfathered units. Keep contract notes and corporate-action records; the burden of proving the pre-2017 acquisition date is on you, and a demat statement showing only the current balance will not establish it.

Remittance of foreign income to Singapore. Singapore's territorial system means foreign-sourced income is generally not taxed even when received in Singapore by an individual, which is more generous than the UK's old remittance basis. So bringing your Indian dividend or the sale proceeds of Indian shares into your Singapore bank account does not, by itself, create a Singapore tax charge for an individual. The narrow exception is foreign income received in Singapore through a partnership carrying on a trade or business in Singapore, which is not the retail investor's situation. For an ordinary salaried NRI investing on the side, remitting Indian proceeds home is tax-neutral in Singapore. Do not confuse this with the Indian repatriation rules, which are an exchange-control matter under FEMA, not a tax matter, and are covered in the repatriating investment proceeds guide.

Mutual fund units are not shares. The Third Protocol changed the treatment of shares of a company. It did not touch units of an Indian mutual fund, because in India a mutual fund is constituted as a trust and a unit is a beneficial interest in that trust, not equity in a company. So the date-based source rule for share gains does not reach mutual fund units; gains on them fall under the residual capital gains article, which assigns the gain to the residence state, Singapore, where it is taxed at zero. The practical upshot is striking: a Singapore-resident NRI's gain on an equity mutual fund bought in 2021 can be taxable only in Singapore (zero), while the same investor's gain on direct shares bought in 2021 is fully taxable in India. This position has been upheld by the ITAT but is not formally settled by statute, so it is a strong claim rather than a certainty, and it should be made with proper documentation and ideally professional sign-off. The fuller treatment, including the case law, is in the India-Singapore DTAA deep dive.

Derivatives and intraday. Gains from futures and options on Indian exchanges are generally treated as business income rather than capital gains, both under Indian domestic law and for treaty purposes, which puts them under the business-profits article rather than the capital gains article. For a Singapore resident without a permanent establishment in India, business profits are typically taxable only in Singapore, but the characterisation is fact-specific and the volume and frequency of trading matter. This is genuinely unsettled territory for active traders, and a high-frequency F&O book is not something to self-assess on a treaty position without advice. If your Indian activity is investment in shares and funds, you are in the clean zone described above; if it is active derivatives trading, treat it as a separate, more complex question.

TDS and the Indian return still apply. Singapore not taxing the gain does not excuse you from the Indian side. On a sale of listed shares by a non-resident, the buyer or the broker mechanism deducts TDS, and you may need to file an Indian return to reconcile the TDS against the actual Section 112A liability and claim any refund of over-deduction. Your residency status under Indian law, and whether you are a non-resident or an RNOR in a transition year, changes what India can tax in the first place; the NRI residency and RNOR rules set the boundary. Do not assume that because Singapore is silent, India is satisfied without a filing.

The closing read

The honest read on being a Singapore-resident NRI in 2026 is that your home country is doing you a quiet, large favour, and it has nothing to do with the treaty. Singapore's zero capital gains tax and territorial treatment of foreign income mean your Indian gains and dividends are simply not part of the Singapore tax base. That removes the entire double-tax apparatus that defines investing for US and UK resident NRIs: no foreign tax credit forms, no PFIC regime, no remittance traps for the ordinary investor. The Indian tax you pay is the whole tax you pay.

But the treaty is no longer the hero of this story, and pretending otherwise is the expensive mistake. The zero-Indian-tax-on-shares route died on 1 April 2017. For anything you bought after 2019, India charges the full domestic rate, 20% short-term and 12.5% long-term, and the treaty does not touch it. Only genuinely old holdings, acquired before April 2017, keep the grandfathered exemption, and only mutual fund units sidestep the share rule on a defensible technicality. So plan around the Indian rules, not the treaty: time disposals for the long-term rate where you can, use the Rs 1,25,000 annual exemption, document acquisition dates lot by lot, and claim the 15% treaty rate on dividends with a TRC and Form 10F before each registrar's cut-off. The structure that makes Singapore attractive is real and durable. The specific loophole most people still talk about is gone, and the sooner you stop relying on it, the cleaner your filings will be.

Related guides

• The India-Singapore DTAA deep dive
• The Mauritius and Singapore grandfathering, explained
• Capital gains tax for NRIs on shares and mutual funds
• Foreign tax credit and Form 67 for NRIs
• NRI residency and the RNOR rules
• How NRI dividends from Indian companies are taxed
• Buying Indian stocks through the PIS route
• GIFT City investing for NRIs
• Tax-efficient investing for NRIs
• NRI portfolio asset allocation
• The UAE zero-CGT route under the India-UAE DTAA

Disclaimer

This guide is general information for NRIs resident in Singapore, not personal tax advice, and it does not create an adviser relationship. Tax rates, treaty positions, and the characterisation of mutual fund units and derivatives can change and depend on your specific facts, including your exact acquisition dates and your residency status in any given year. The mutual fund and derivatives positions described here are defensible but not formally settled by statute. Singapore's territorial treatment of foreign income has its own conditions, and your IRAS residency status matters. Confirm your position with a qualified chartered accountant in India and a tax adviser in Singapore before acting, especially on a large disposal or an active trading book.